After graduating from high school in 1983, Dr. Pasquale Niscola completed his medical training at Sapienza University of Rome, graduating in Medicine and Surgery (Laurea in Medicina e Chirurgia) on October 24, 1990. He subsequently joined the postgraduate residency program in Hematology at the First Specialization School of Hematology of Sapienza University of Rome, mentored by Professor Franco Mandelli. He graduated in Hematology on November 17, 1994, with highest honors (70/70). Dr. Niscola works within the public healthcare sector of Rome, Italy, at Sant’Eugenio Hospital under ASL Roma 2. His main research interests include Health-Related Quality of Life (HRQoL) and patient-reported outcomes (PROs). Within the Italian Group for Adult Hematologic Diseases (GIMEMA), he is Co-Chairman and an executive board member of the Quality-of-Life Working Party. His research assesses physical fatigue, psychological distress, and functional condition of patients to measure the impact of treatment approaches on HRQoL. He is a Regional Editor of Cardiovascular & Hematological Agents in Medicinal Chemistry and Associate Editor of Frontiers in Oncology. He has been the author/co-author of >300 scientific publications, and has >4,600 citations and an h-index of 27 (ORCID: https://orcid.org/0000-0002-2226-6518). His career demonstrates the evolving clinical approach in modern hematology, integrating targeted therapies with patient-centered care, particularly in MDS and AML.